These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30925301)

  • 1. Using stem cell-derived neurons in drug screening for neurological diseases.
    Little D; Ketteler R; Gissen P; Devine MJ
    Neurobiol Aging; 2019 Jun; 78():130-141. PubMed ID: 30925301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting pluripotent stem cell technology for drug discovery, screening, safety, and toxicology assessments.
    McGivern JV; Ebert AD
    Adv Drug Deliv Rev; 2014 Apr; 69-70():170-8. PubMed ID: 24309014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids.
    Costamagna G; Comi GP; Corti S
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Throughput Phenotypic Screening of Human Astrocytes to Identify Compounds That Protect Against Oxidative Stress.
    Thorne N; Malik N; Shah S; Zhao J; Class B; Aguisanda F; Southall N; Xia M; McKew JC; Rao M; Zheng W
    Stem Cells Transl Med; 2016 May; 5(5):613-27. PubMed ID: 27034412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platform.
    Garcia-Leon JA; Vitorica J; Gutierrez A
    Future Med Chem; 2019 Jun; 11(11):1305-1322. PubMed ID: 31161803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional screening assays with neurons generated from pluripotent stem cell-derived neural stem cells.
    Efthymiou A; Shaltouki A; Steiner JP; Jha B; Heman-Ackah SM; Swistowski A; Zeng X; Rao MS; Malik N
    J Biomol Screen; 2014 Jan; 19(1):32-43. PubMed ID: 24019252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Promise and Perils of Compound Discovery Screening with Inducible Pluripotent Cell-Derived Neurons.
    Sharlow ER; Koseoglu MM; Bloom GS; Lazo JS
    Assay Drug Dev Technol; 2020; 18(2):97-103. PubMed ID: 31095406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Human Neural Progenitor Cell Models to Conduct Large-Scale Drug Screens for Neurological and Psychiatric Diseases.
    Hunt JFVS; Li M; Zhao X; Bhattacharyya A
    Methods Mol Biol; 2019; 1942():79-88. PubMed ID: 30900177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human stem cells for modeling neurological disorders: accelerating the drug discovery pipeline.
    Crook JM; Kobayashi NR
    J Cell Biochem; 2008 Dec; 105(6):1361-6. PubMed ID: 18980214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emerging Role of Neuronal Organoid Models in Drug Discovery: Potential Applications and Hurdles to Implementation.
    Struzyna LA; Watt ML
    Mol Pharmacol; 2021 Apr; 99(4):256-265. PubMed ID: 33547249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. iPS cell derived neuronal cells for drug discovery.
    Heilker R; Traub S; Reinhardt P; Schöler HR; Sterneckert J
    Trends Pharmacol Sci; 2014 Oct; 35(10):510-9. PubMed ID: 25096281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson's Disease for Drug Identification.
    Kouroupi G; Antoniou N; Prodromidou K; Taoufik E; Matsas R
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells for neural drug discovery.
    Farkhondeh A; Li R; Gorshkov K; Chen KG; Might M; Rodems S; Lo DC; Zheng W
    Drug Discov Today; 2019 Apr; 24(4):992-999. PubMed ID: 30664937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening.
    Eglen R; Reisine T
    Assay Drug Dev Technol; 2011 Apr; 9(2):108-24. PubMed ID: 21186936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases.
    Zhang X; Hu D; Shang Y; Qi X
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165431. PubMed ID: 30898538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studying human disease using human neurons.
    Ahfeldt T; Litterman NK; Rubin LL
    Brain Res; 2017 Feb; 1656():40-48. PubMed ID: 27060768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease.
    Garcia-Leon JA; Caceres-Palomo L; Sanchez-Mejias E; Mejias-Ortega M; Nuñez-Diaz C; Fernandez-Valenzuela JJ; Sanchez-Varo R; Davila JC; Vitorica J; Gutierrez A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated large-scale culture and medium-throughput chemical screen for modulators of proliferation and viability of human induced pluripotent stem cell-derived neuroepithelial-like stem cells.
    McLaren D; Gorba T; Marguerie de Rotrou A; Pillai G; Chappell C; Stacey A; Lingard S; Falk A; Smith A; Koch P; Brüstle O; Vickers R; Tinsley J; Flanders D; Bello P; Craig S
    J Biomol Screen; 2013 Mar; 18(3):258-68. PubMed ID: 23042076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pluripotent Stem Cell-Derived Human Tissue: Platforms to Evaluate Drug Metabolism and Safety.
    Meseguer-Ripolles J; Khetani SR; Blanco JG; Iredale M; Hay DC
    AAPS J; 2017 Dec; 20(1):20. PubMed ID: 29270863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.